Protein manufacture
The present invention provides a novel method for protein manufacture wherein the protein is expressed in a host cell, and in a more specific manner relates to a method for manufacturing a protein that results in reduced levels of product-related impurities.
1. A method for manufacturing a protein of interest in a prokaryotic host cell comprising:
a) culturing prokaryotic host cells under conditions such that said cells express a protein of interest having a higher melting temperature than the melting temperature of host cell proteins,
b) collecting said host cells from the cell culture fluid,
c) adding buffer to said host cells, and
d) subjecting said host cells to heat treatment at a temperature of between 30° C. to 70° C. to melt host cell proteins while said protein of interest is not melted at said temperature and maintaining the redox potential of said buffer below −0 mV during said heat treatment.
2. The method according to claim 1 , wherein the heat treatment is performed in a container and said redox potential is maintained by reducing the amount of oxygen (O 2 ) present in the gaseous phase in the container during protein extraction.
3. The method according to claim 2 , wherein nitrogen (N 2 ) is added to the gaseous phase of the container.
4. The method according to claim 3 , wherein said gaseous phase contains at least 50% N 2 .
5. The method according to claim 3 , wherein said N 2 is added to the container as an overlay in the gaseous phase of the container or by sparging the N 2 through the sample.
6. The method according to claim 1 , wherein said heat treatment step is performed at 55° C. to 65° C.
7. The method according to claim 1 , wherein said heat treatment is performed for a period of 1 to 18 hours.
8. The method according to claim 1 , wherein the pH of the buffer, following addition to the host cells and prior to the heat treatment, is measured.
9. The method according to claim 8 , wherein the pH of the buffer is a pH of 6 to 9 or is adjusted to a pH of 6 to 9.
10. The method according to claim 1 , wherein the protein of interest is a recombinant protein encoded in an expression vector.
11. The method according to claim 10 , wherein the protein of interest is a recombinant antibody.
12. The method according to claim 11 , wherein said recombinant antibody is a recombinant antibody fragment that binds to an antigen.
13. The method according to claim 11 , wherein said recombinant antibody specifically binds to TNF-alpha or CD154.
14. The method according to claim 12 , wherein said antibody fragment specifically binds to TNF-alpha or CD154.
15. The method according to claim 12 , wherein said recombinant antibody fragment is a Fab, Fab′, F(ab′) 2 , Fv, scFv diabody, triabody, tetrabody, minibody, domain antibody (dAbs), sdAb, V H H, V NAR , single-chain antibody, a multispecific antibody formed from antibody fragments, Fab-Fv or Fab-Fv-Fv.